Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Lamivudine

Lamivudine

pharmaceutical raw materials
Lamivudine structure

Lamivudine 

structure
  • CAS No:

    134678-17-4

  • Formula:

    C8H11N3O3S

  • Chemical Name:

    Lamivudine

  • Synonyms:

    2(1H)-Pyrimidinone,4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-;2(1H)-Pyrimidinone,4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-;1,3-Oxathiolane,2(1H)-pyrimidinone deriv.;4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone;(-)-BCH 189;GR 109714X;Lamivudine;BCH 189,(-)-;(-)-2′-Deoxy-3′-thiacytidine;β-L-3′-Thia-2′,3′-dideoxycytidine;Epivir;Zeffix;Heptovir;Epivir HBV;L-SddC;Zefix;Hepitec;β-L-2′,3′-Dideoxy-3′-thiacytidine;3TC;Lamivir;Heptodin;Virolam;2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane;cis(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane;Lamidine;29: PN: WO2016077321 SEQID: 29 claimed sequence;Hiviral;480434-79-5;1117764-41-6

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

Lamivudine is a nucleoside reverse transcriptase inhibitors?(NRTIs). Lamivudine can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus.

Lamivudine Basic Attributes

229.26

229.26

1806241-263-5

760061|620753

DTXSID10274412

2938901000

Characteristics

113

-0.9

white to beige

1.7±0.1 g/cm3

160-162 °C

475.4°C at 760 mmHg

9℃

-142 ° (C=1, MeOH)

70g/L(temperature not stated)

Freezer

8.3X10-16 mm Hg @ 25 deg C /Estimated/

D21 -135° (c = 0.38 in methanol)

Safety Information

UN1230 - class 3 - PG 2 - Methanol, solution

3

63-36/37/38

26-36

UW7361333

P281

H361

Lamivudine Use and Manufacturing

A reverse transcriptase inhibitor. Antiviral.

Computed Properties

Molecular Weight:229.26
XLogP3:-0.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:2
Exact Mass:229.05211239
Monoisotopic Mass:229.05211239
Topological Polar Surface Area:113
Heavy Atom Count:15
Complexity:331
Undefined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Material

Drug Function and Efficacy

Lamivudine is a nucleoside antiviral drug. It has a strong inhibitory effect on hepatitis B virus (HBV) in vitro and in experimentally infected animals. Lamivudine can be metabolized in HBV-infected cells and normal cells to produce lamivudine triphosphate, which is the active form of lamivudine and is both an inhibitor of HBV polymerase and a substrate of this polymerase. Lamivudine triphosphate penetrates into the viral DNA chain and blocks the synthesis of viral DNA. Lamivudine triphosphate does not interfere with the metabolism of deoxynucleosides in normal cells. It has a weak inhibitory effect on mammalian DNA polymerase α and β and has almost no effect on the DNA content of mammalian cells. Lamivudine has no obvious toxicity to the structure, DNA content and function of mitochondria. The results of serum HBVDNA detection in most hepatitis B patients showed that lamivudine can rapidly inhibit HBV replication, and its inhibitory effect lasts throughout the treatment process, while reducing serum aminotransferase to normal. Long-term use can significantly improve liver necrosis and inflammatory changes, and reduce or prevent the progression of liver fibrosis.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • ARENE LIFE SCIENCES PRIVATE LTD

    United States United States
    Active
  • LAURUS LABS LTD

    United States United States
    Active
  • MATRIX PHARMACORP PRIVATE LTD

    United States United States
    Active

Recommended Suppliers of Lamivudine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.